Home › Non-Small Cell Lung Cancer › California › Sunnyvale

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Sunnyvale, CA

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sunnyvale. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

Palo Alto Medical Foundation-Sunnyvale, Sunnyvale

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Nagre-recruitPhase 3

Clinical Study Site, Sunnyvale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06767514

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Palo Alto Medical Foundation-Sunnyvale, Sunnyvale

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Palo Alto Medical Foundation-Sunnyvale, Sunnyvale

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Palo Alto Medical Foundation-Sunnyvale, Sunnyvale

18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Sunnyvale

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.